CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

Nature

Volumn 391, Issue 6667, 1998, Pages 591-594

  Henn, Volker ^a   Slupsky, Joseph R ^b   Gräfe, Michael ^c   Anagnostopoulos, Ioannis ^d   Förster, Reinhold ^e   Müller Berghaus, Gert ^b   Kroczek, Richard A ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; VASCULAR DISEASE;

ANTIGENS, CD40; BLOOD PLATELETS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; MEMBRANE GLYCOPROTEINS; PLATELET ACTIVATION; THROMBOSIS; VASCULITIS;

THROMBUS;

EID: 0032484987     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35393     Document Type: Article

References (29)

1. Armitage, R. J. et al. Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80-82 (1992).
2. Graf, D., Korthäuer, U., Mages, H. W., Senger, G, & Kroczek, R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22, 3191-3194 (1992).
3. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175, 1091-1101 (1992).
4. Gauchat, J. F. et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340-343 (1993).
5. Kroczek, R. A. et al. Defective expression of CD40 ligand on T cells causes X-linked immunodeficiency with hyper-IgM (HIGM1)". Immunol. Rev. 138, 39-59 (1994).
6. Nieuwenhuis, H. K., van Oosterhout, J. J., Rozemuller, E., van Iwaarden, F. & Sixma, J. J. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70, 838-845 (1987).
7. Holmsen, H. in Hemostasis and Thrombosis (eds Colman, R. W., Hirsh, J., Marder, V. J. & Salzman, E. W.) 3rd edn, 524-545 (Lippincott, Philadelphia, 1994).
8. Graf, D. et al. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25, 1749-1754 (1995).
9. Lauffer, L. et al. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential. Behring Inst. Mitt. 96, 21-31 (1995).
10. Yellin, M. J. et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182, 1857-1864 (1995).
11. Hollenbaugh, D. et al. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182, 33-40 (1995).
12. Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C. & Pober, J. S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl Acad. Sci. USA 92, 4342-4346 (1995).
13. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314 (1994).
14. Bevilacqua, M. P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11, 767-804 (1993).
15. Ebnet, K., Kaldjian, E. P., Anderson, A. O. & Shaw, S. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 14, 155-177 (1996).
16. Baggiolini, M., Dewald, B. & Moser, B. Interieukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55, 97-178 (1994).
17. Ware, J. A. & Heistad, D. D. Platelet-endothelium interactions. N. Engl. J. Med. 328, 628-635 (1993).
18. Clark, R. A. F. in The Molecular and Cellular Biology of Wound Repair (ed. Clark, R. A. F.) 2nd edn, 3-50 (Plenum, New York, 1996).
19. Alderson, M. R. et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669-674 (1993).
20. Caux, C. et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272 (1994).
21. Kiener, P. A. et al. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155, 4917-4925 (1995).
22. Hawrylowicz, C. M., Howells, G. L. & Feldman, M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J. Exp. Med. 174, 785-790 (1991).
23. Kaplanski, G. et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81, 2492-2495 (1993).
24. Davies, M. J. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb. Res. 82, 1-32 (1996).
25. Kenny, D., Newman, P. J., Morateck, P. A. & Montgomery, R. A. A dinucleotide deletion results in defective membrane anchoring and circulating soluble glycoprotein Ibα in a novel form of Bernard-Soulier syndrome. Blood 90, 2626-2633 (1997).
26. Cordell, J. L. et al. Immuno-enzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32, 219-229 (1984).
27. Korthäuer, U. et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539-541 (1993).
28. Ogura, M. et al. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 66, 1384-1392 (1985).
29. Komatsu, N. et al. Establishment and characterization of a human Ieukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interieukin 3, or erythropoietin for growth and survival. Cancer Res. 51, 341-348 (1991).